Autophagy-Derived Metabolites as Epigenetic Rheostats in Cellular Siege Responses

Autophagy functions as a siege‑rationing system that decides which intracellular components to sacrifice for survival. Beyond providing amino acids and lipids, the degradation process generates specific metabolites—acetyl‑CoA, succinate, NAD+, and α‑ketoglutarate—that can exit the lysosome via transporters such as SLC25A1 (citrate) and SLC13A5 (succinate). These metabolites act as epigenetic cofactors: acetyl‑CoA fuels histone acetylation, succinate and α‑ketoglutarate modulate histone and DNA demethylases, and NAD+ drives sirtuin‑dependent deacetylation. We hypothesize that the flux of autophagy‑derived metabolites constitutes a metabolic‑epigenetic rheostat that re‑programs gene expression to match the severity and duration of cellular stress.

During acute stress (e.g., early iPSC reprogramming days 1‑3), a transient autophagy burst produces a pulse of acetyl‑CoA and NAD+ that transiently opens chromatin at pluripotency loci, facilitating Sox2‑driven mTOR downregulation and metabolic shift to glycolysis [8][9]. If autophagy persists beyond this window, sustained metabolite export leads to chronic histone hyper‑acetylation and aberrant expression of differentiation‑suppressing genes, ultimately reducing reprogramming efficiency—a prediction supported by the loss of efficiency when Atg5/7/3 are deficient or when autophagy is prolonged [9].

In neurodegeneration, chronic ER‑stress or inflammatory signaling upregulates OPTN and SEC62 receptors, driving selective ER‑phagy and mitochondrial turnover [3][4]. The resulting metabolite surplus may aberrantly activate HDAC inhibitors or sirtuins, shifting the balance toward a pro‑survival but epigenetically locked state that impairs neuronal plasticity and promotes α‑synuclein accumulation when the triage system fails [5][6][7]. Conversely, boosting NAD+ salvage (e.g., with NR) should counteract deleterious succinate‑mediated inhibition of TET enzymes, restoring DNA demethylation and improving autophagy‑dependent clearance.

Testable predictions:

1. Pharmacological blockade of lysosomal citrate export (SLC25A1) will diminish acetyl‑CoA‑dependent histone H3K27ac at pluripotency promoters during day 2 of iPSC reprogramming, reducing colony formation without affecting bulk autophagy flux.
2. In microglia‑neuron cocycles, overexpression of the succinate transporter SLC13A5 will increase nuclear succinate levels, inhibit KDM5 histone demethylases, and exacerbate α‑synuclein‑induced toxicity; rescuing with cell‑permeable α‑ketoglutarate should reverse this effect.
3. NAD+ augmentation will normalize histone acetylation patterns in neurons subjected to chronic tunicamycin‑induced ER stress, decreasing p62‑positive aggregates and improving survival, an effect blocked by lysosomal NAD+ transporter (SLC25A51) knockdown.

These experiments directly link autophagy‑mediated metabolite trafficking to epigenetic remodeling, extending the siege‑rationing concept from mere catabolism to active instructional signaling. If metabolite flux fails to correlate with predicted epigenetic and phenotypic outcomes, the hypothesis would be falsified, prompting a reassessment of autophagy’s role as a passive recycling pathway versus an active metabolic‑epigenetic regulator in stressed cells.